What is the accuracy (sensitivity) of an HSV‑1/HSV‑2 IgG test at 3 weeks and at 4 weeks after exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

HSV IgG Test Accuracy at 3 and 4 Weeks Post-Exposure

IgG testing at 3 or 4 weeks after exposure is unreliable and should not be performed—you need to wait at least 12 weeks for accurate results. 1

Why Testing Before 12 Weeks Is Problematic

Antibody Development Timeline

  • Detectable IgG antibodies typically do not appear until up to 12 weeks after HSV exposure, making early testing prone to false-negative results. 1
  • The incubation period for HSV-1 and HSV-2 ranges from 2 to 10 days (up to 4 weeks), but this refers to symptom onset, not antibody development. 2
  • Testing performed before 12 weeks post-exposure should be deferred; repeat testing is recommended no sooner than 12 weeks after the suspected exposure. 1

Baseline Test Performance (Even at Optimal Timing ≥12 Weeks)

Even when performed at the recommended ≥12-week timepoint, commercial HSV IgG assays have significant limitations:

  • HSV-1 IgG sensitivity is only approximately 70%, meaning about 30% of truly infected individuals receive false-negative results. 1
  • HSV-2 IgG sensitivity is higher at approximately 92%, but still misses roughly 8% of true infections. 1
  • Recent 2024 data confirms HSV-1 IgG sensitivity remains <85% across major platforms (Bio-Rad, Roche), while HSV-2 IgG achieves >97% sensitivity. 3

What This Means for 3-4 Week Testing

At 3-4 weeks, the accuracy is essentially unknown but presumed to be substantially lower than the already-poor baseline sensitivities listed above, because many patients have not yet seroconverted. 1

  • A negative result at 3-4 weeks is clinically meaningless and cannot exclude HSV infection. 1
  • Even a positive result may represent cross-reactivity or prior infection rather than recent exposure.

Clinical Recommendations

When Active Lesions Are Present

  • Perform HSV nucleic acid amplification testing (NAAT/PCR) directly from the lesion—this is the gold-standard diagnostic method with >90% sensitivity and specificity. 1
  • Do not rely on serology when lesions are available for direct testing. 1

When No Lesions Are Present

  • Wait until ≥12 weeks after suspected exposure before ordering type-specific HSV-1 and HSV-2 IgG serology. 1
  • Use assays that detect antibodies to HSV glycoprotein G-1 and G-2 via enzyme immunoassay (EIA) or chemiluminescent immunoassay (CLIA). 1

Critical Pitfalls to Avoid

  • Do not tell patients that a negative serology at any timepoint definitively excludes HSV—false-negative rates are substantial (≈30% for HSV-1, ≈8% for HSV-2 even at optimal timing). 1
  • When HSV-2 serology yields a low index value (1.1-2.9), specificity drops to approximately 39.8%, meaning confirmatory testing should be considered. 1
  • Individuals with prior HSV-1 infection are more prone to false-positive HSV-2 results when the HSV-2 index value is low. 1

Bottom Line

There is no reliable accuracy percentage for IgG testing at 3-4 weeks because antibodies have not yet developed in most patients. The only appropriate action is to either test active lesions with PCR or wait until 12 weeks post-exposure for serology. 1

References

1
Guideline

Guideline Recommendations for HSV‑1 and HSV‑2 Diagnostic Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the accuracy (sensitivity and specificity) of an HSV IgG test performed 3–4 weeks after exposure?
What does a high HSV‑2 IgG antibody index indicate and how should it be managed?
Is a 25–35 % probability of a borderline HSV‑2 IgG result considered a high chance of true early HSV‑2 infection?
What is the significance of HSV‑1 IgG 11 and HSV‑2 IgG 5.66 (HSV‑2 positive) and what management is recommended?
What is the significance of a positive leukocyte screen and an HSV‑1 IgG level of 29.4 AU/mL, and what management is recommended?
What organisms might be represented by gram‑negative bacilli isolated from a wound culture?
Is cefdinir appropriate for treating a complicated urinary tract infection in a man?
What is the appropriate dose of Lokelma (sodium zirconium cyclosilicate) for an adult with a serum potassium of 5.2 mmol/L who is not on dialysis?
In a patient who developed a transient ischemic attack after a clot evacuation procedure and has hematuria, how should dual antiplatelet therapy be initiated?
What is the Yasui procedure?
What is the recommended intramuscular dosing of ziprasidone (Geodon)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.